Salvia GmbH, Author at Salvia GmbH https://salvia.de/author/salvia-gmbh/ Wir unterstützen heute innovative Unternehmen von morgen mit Kapital, Know-how und Netzwerk. Tue, 19 May 2026 09:03:47 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.8 https://salvia.de/wp-content/uploads/2021/05/cropped-salvia-icon-square-520x520-whitebg-32x32.png Salvia GmbH, Author at Salvia GmbH https://salvia.de/author/salvia-gmbh/ 32 32 Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis https://salvia.de/en/bambusa-therapeutics-completes-patient-enrollment-in-the-phase-1b-2a-trial-evaluating-bbt001-as-a-treatment-for-atopic-dermatitis/ Tue, 19 May 2026 09:03:47 +0000 https://salvia.de/?p=1730 Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis

The post Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis appeared first on Salvia GmbH.

]]>

Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis

The post Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis appeared first on Salvia GmbH.

]]> IQM and Real Asset Acquisition Corp. Announce Public Filing of Form F-4 Registration Statement with the SEC https://salvia.de/en/iqm-and-real-asset-acquisition-corp-announce-public-filing-of-form-f-4-registration-statement-with-the-sec/ Tue, 19 May 2026 08:44:32 +0000 https://salvia.de/?p=1728 IQM and Real Asset Acquisition Corp. Announce Public Filing of Form F-4 Registration Statement with the SEC

The post IQM and Real Asset Acquisition Corp. Announce Public Filing of Form F-4 Registration Statement with the SEC appeared first on Salvia GmbH.

]]>

IQM and Real Asset Acquisition Corp. Announce Public Filing of Form F-4 Registration Statement with the SEC

The post IQM and Real Asset Acquisition Corp. Announce Public Filing of Form F-4 Registration Statement with the SEC appeared first on Salvia GmbH.

]]> Zadient https://salvia.de/en/zadient/ Wed, 25 Feb 2026 17:23:16 +0000 https://salvia.de/?p=1711 The forward-looking business model of French company Zadient Technology is the production of silicon carbide as a base material for power semiconductors, which are used in inverters and chargers in the rapidly growing electric vehicle market, among other applications.

The post Zadient appeared first on Salvia GmbH.

]]> The forward-looking business model of French company Zadient Technology is the production of silicon carbide as a base material for power semiconductors, which are used in inverters and chargers in the rapidly growing electric vehicle market, among other applications.

The post Zadient appeared first on Salvia GmbH.

]]> IQM, a Global Leader for Quantum Computing, to Become the First Listed European Quantum Company, Through Merger with Real Asset Acquisition Corp. https://salvia.de/en/iqm-a-global-leader-for-quantum-computing-to-become-the-first-listed-european-quantum-company-through-merger-with-real-asset-acquisition-corp/ Wed, 25 Feb 2026 16:17:12 +0000 https://salvia.de/?p=1703 The post IQM, a Global Leader for Quantum Computing, to Become the First Listed European Quantum Company, Through Merger with Real Asset Acquisition Corp. appeared first on Salvia GmbH.

]]>

IQM, a Global Leader for Quantum Computing, to Become the First Listed European Quantum Company, Through Merger with Real Asset Acquisition Corp.

The post IQM, a Global Leader for Quantum Computing, to Become the First Listed European Quantum Company, Through Merger with Real Asset Acquisition Corp. appeared first on Salvia GmbH.

]]> Bambusa Therapeutics Announces Highly Positive Healthy Volunteer Results and First Atopic Dermatitis Patient Dosed in Phase I Trial of BBT001 https://salvia.de/en/bambusa-therapeutics-announces-highly-positive-healthy-volunteer-results-and-first-atopic-dermatitis-patient-dosed-in-phase-i-trial-of-bbt001/ Thu, 25 Sep 2025 15:36:24 +0000 https://salvia.de/?p=1708 The post Bambusa Therapeutics Announces Highly Positive Healthy Volunteer Results and First Atopic Dermatitis Patient Dosed in Phase I Trial of BBT001 appeared first on Salvia GmbH.

]]>

Bambusa Therapeutics Announces Highly Positive Healthy Volunteer Results and First Atopic Dermatitis Patient Dosed in Phase I Trial of BBT001

The post Bambusa Therapeutics Announces Highly Positive Healthy Volunteer Results and First Atopic Dermatitis Patient Dosed in Phase I Trial of BBT001 appeared first on Salvia GmbH.

]]> Bambusa Therapeutics successfully raises USD 90m in Series A https://salvia.de/en/bambusa-therapeutics-successfully-raises-usd-90m-in-series-a/ Mon, 28 Apr 2025 11:58:42 +0000 https://salvia.de/?p=1664 For more information visit: https://www.prnewswire.com/news-releases/bambusa-therapeutics-raises-approximately-90-million-in-series-a-financing-to-advance-next-generation-bispecific-antibodies-for-immunology–inflammation-diseases-302376866.html

The post Bambusa Therapeutics successfully raises USD 90m in Series A appeared first on Salvia GmbH.

]]> For more information visit: https://www.prnewswire.com/news-releases/bambusa-therapeutics-raises-approximately-90-million-in-series-a-financing-to-advance-next-generation-bispecific-antibodies-for-immunology–inflammation-diseases-302376866.html

The post Bambusa Therapeutics successfully raises USD 90m in Series A appeared first on Salvia GmbH.

]]> InPlanet, is now the first climate tech company to develop and deliver certified carbon credits using Enhanced Rock Weathering! https://salvia.de/en/inplanet-is-now-the-first-climate-tech-company-to-develop-and-deliver-certified-carbon-credits-using-enhanced-rock-weathering/ Mon, 20 Jan 2025 12:12:09 +0000 https://salvia.de/?p=1655 See further details under: https://inplanet.earth/press/worlds-first-enhanced-rock-weathering-carbon-removal-credits-issued/

The post InPlanet, is now the first climate tech company to develop and deliver certified carbon credits using Enhanced Rock Weathering! appeared first on Salvia GmbH.

]]> See further details under: https://inplanet.earth/press/worlds-first-enhanced-rock-weathering-carbon-removal-credits-issued/

The post InPlanet, is now the first climate tech company to develop and deliver certified carbon credits using Enhanced Rock Weathering! appeared first on Salvia GmbH.

]]> Bambusa Therapeutics https://salvia.de/en/bambusa-therapeutics/ Thu, 12 Sep 2024 12:02:16 +0000 https://salvia.de/?p=1602 Bambusa Therapeutics is a rapidly growing biotechnology company specializing in developing transformative inflammatory and immunological therapeutics. Based in the vibrant Boston Seaport area, our mission is to advance the field of immunology with cutting-edge solutions.

The post Bambusa Therapeutics appeared first on Salvia GmbH.

]]> Bambusa Therapeutics is a rapidly growing biotechnology company specializing in developing transformative inflammatory and immunological therapeutics. Based in the vibrant Boston Seaport area, our mission is to advance the field of immunology with cutting-edge solutions.

The post Bambusa Therapeutics appeared first on Salvia GmbH.

]]> Bambusa Therapeutics successfully closes Series Seed https://salvia.de/en/bambusa-therapeutics-successfully-closes-series-seed/ Thu, 12 Sep 2024 11:54:13 +0000 https://salvia.de/?p=1599 For more information visit: https://www.prnewswire.com/news-releases/bambusa-therapeutics-inc-announces-successful-series-seed-funding-to-advance-innovative-bispecific-antibodies-for-immunology–inflammation-302241958.html?tc=eml_cleartime

The post Bambusa Therapeutics successfully closes Series Seed appeared first on Salvia GmbH.

]]> For more information visit: https://www.prnewswire.com/news-releases/bambusa-therapeutics-inc-announces-successful-series-seed-funding-to-advance-innovative-bispecific-antibodies-for-immunology–inflammation-302241958.html?tc=eml_cleartime

The post Bambusa Therapeutics successfully closes Series Seed appeared first on Salvia GmbH.

]]> One Data closes EUR 32 million Series B Extension https://salvia.de/en/one-data-closes-eur-32-million-series-b-extension-2/ Wed, 17 Jul 2024 12:33:13 +0000 https://salvia.de/?p=1586 Further details: https://onedata.ai/one-data-closes-eur-32-million-series-b-extension/

The post One Data closes EUR 32 million Series B Extension appeared first on Salvia GmbH.

]]> Further details: https://onedata.ai/one-data-closes-eur-32-million-series-b-extension/

The post One Data closes EUR 32 million Series B Extension appeared first on Salvia GmbH.

]]>